EXPAREL® (bupivacaine liposome)
Acute Post-Surgical Pain (Pediatric 0 to < 6 years)
Phase 3Active
Key Facts
Indication
Acute Post-Surgical Pain (Pediatric 0 to < 6 years)
Phase
Phase 3
Status
Active
Company
About Pacira Biosciences
Pacira BioSciences is a publicly traded company on a mission to transform pain management by delivering innovative, non-opioid therapies. For over a decade, it has been a leader in the field, commercializing best-in-class products like EXPAREL® and ZILRETTA® while actively advocating for policy changes to expand patient access to non-opioid options. The company's strategic direction focuses on expanding its commercial portfolio, advancing a pipeline that includes a novel gene therapy, and addressing the significant unmet needs in musculoskeletal and postsurgical pain.
View full company profile